I agree that this site is using cookies. You can find further informations here.
X
Namrata Vijayvergia
44  results:
Search for persons X
?
1

Narrative Review of Immunotherapy in Gastroentero-Pancreati..:

Kaur, Jasmeet ; Vijayvergia, Namrata
Current Oncology.  30 (2023)  9 - p. 8653-8664 , 2023
Link: https://doi.org/10.3390/..
 
?
2

The room where it happens: addressing diversity, equity, an..:

Snyder, Rebecca A ; Burtness, Barbara ; Cho, May...
JNCI: Journal of the National Cancer Institute.  115 (2023)  10 - p. 1132-1138 , 2023
Link: https://doi.org/10.1093/..
 
?
3

Venous thromboembolism in metastatic pancreatic cancer:

Laderman, Lauren ; Sreekrishnanilayam, Krishnalatha ; Pandey, Ramesh K....
European Journal of Haematology.  110 (2023)  6 - p. 706-714 , 2023
Link: https://doi.org/10.1111/..
 
?
4

Expert Consensus Practice Recommendations of the North Amer..:

Eads, Jennifer R ; Halfdanarson, Thorvardur R ; Asmis, Tim...
Endocrine-Related Cancer.  30 (2023)  8 - p. , 2023
Link: https://doi.org/10.1530/..
 
?
5

Narrative Review of Immunotherapy in Gastroentero-Pancreati..:

Jasmeet Kaur ; Namrata Vijayvergia
https://www.mdpi.com/1718-7729/30/9/627.  , 2023
Link: https://doi.org/10.3390/..
 
?
6

Comparative Outcomes of Second-line Topoisomerase-I Inhibit..:

Yeung, Ho-Man ; Sreekrishnanilayam, Krishnalatha ; Meeker, Caitlin...
Journal of Gastrointestinal Cancer.  54 (2022)  1 - p. 73-79 , 2022
Link: https://doi.org/10.1007/..
 
?
7

Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumor:

Gubbi, Sriram ; Vijayvergia, Namrata ; Yu, Jian Q..
Hormone and Metabolic Research.  54 (2022)  12 - p. 795-812 , 2022
Link: https://doi.org/10.1055/..
 
?
8

Exploring Real World Outcomes with Nivolumab Plus Ipilimuma..:

Mohamed, Amr ; Vijayvergia, Namrata ; Kurian, Matthew...
Cancers.  14 (2022)  11 - p. 2695 , 2022
Link: https://doi.org/10.3390/..
 
?
9

Incidence of asymptomatic COVID-19 positivity in cancer pat..:

Liu, Lisa ; Ross, Nicole M. ; Handorf, Elizabeth A....
Journal of Cancer Research and Clinical Oncology.  149 (2022)  7 - p. 3243-3247 , 2022
Link: https://doi.org/10.1007/..
 
?
10

A Virtual Tumor Board Platform: A Way to Enhance Decision-M..:

Hopkins, Steven E. ; Vidri, Roberto J. ; Hill, Maureen V...
Journal of Surgical Research.  278 (2022)  - p. 233-239 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Exploring Real World Outcomes with Nivolumab Plus Ipilimuma..:

Amr Mohamed ; Namrata Vijayvergia ; Matthew Kurian...
Cancer Immunology and Immunotherapy.  , 2022
Link: https://doi.org/10.3390/..
 
?
12

Exploring Real World Outcomes with Nivolumab Plus Ipilimuma..:

Amr Mohamed ; Namrata Vijayvergia ; Matthew Kurian...
https://www.mdpi.com/2072-6694/14/11/2695.  , 2022
Link: https://doi.org/10.3390/..
 
?
13

Impacts of pembrolizumab therapy on immune phenotype in pat..:

MacFarlane IV, Alexander W. ; Yeung, Ho-Man ; Alpaugh, R. Katherine...
Cancer Immunology, Immunotherapy.  70 (2021)  7 - p. 1893-1906 , 2021
Link: https://doi.org/10.1007/..
 
?
14

Review and Updates on Approaches to Neoadjuvant Chemotherap..:

Holden, Thomas ; Vijayvergia, Namrata
Current Colorectal Cancer Reports.  17 (2021)  1 - p. 1-9 , 2021
Link: https://doi.org/10.1007/..
 
?
15

First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabi..:

Winer, Arthur ; Denlinger, Crystal S. ; Vijayvergia, Namrata...
Clinical Colorectal Cancer.  20 (2021)  1 - p. e43-e52 , 2021
Link: https://doi.org/10.1016/..
 
1-15